Skip to main content
. Author manuscript; available in PMC: 2010 Jul 27.
Published in final edited form as: Cancer Nurs. 2009 Jul–Aug;32(4):E15–E25. doi: 10.1097/NCC.0b013e3181a0238f

Table 4.

Results* of the IPQ-R attributes over 3 time points** (n=29)

IPQ-R Attributes Possible
Range
Baseline Second Time Point 6 Months

mean (SD) range mean (SD) range mean (SD) Range



Identity***, d (0–14) 4.7 (3.55) 0–12 6.2 (4.29) 0–14 6.6 (3.94) 0–12
Timeline (acute/chronic)a (0–30) 17.8 (4.59) 10–29 17.2 (4.67) 10–27 19.8 (5.50) 8–30
Timeline (cyclical) (0–20) 11.2 (2.35) 6–16 11.8 (2.63) 7–18 11.9 (2.64) 7–16
Personal controlb (0–30) 22.7 (3.51) 12–28 21.8 (3.18) 15–28 20.4 (3.89) 12–26
Treatment controlc (0–25) 19.2 (2.47) 13–24 19.0 (1.88) 15–24 17.8 (3.06) 9–23
Consequence (0–30) 23.7 (3.17) 15–30 22.6 (5.03) 9–30 23.1 (4.54) 10–29
Illness coherence (0–25) 15.9 (4.70) 6–24 16.9 (4.46) 6–23 16.9 (3.87) 9–23
Emotional representation (0–30) 21.0 (5.01) 10–30 19.6 (3.92) 14–27 19.6 (4.03) 12–29
*

Differences between means calculated by within-subjects repeated measures ANOVA except for identity attribute

**

baseline, 2–4 weeks, 6 months

***

Differences between means calculated by Wilcoxon Signed-Rank Tests

a

F=4.310, df=(2,28), p=0.018

b

F=5.495, df=(2,28), p=0.007

c

F=3.239, df=(2,28), p=0.047

d

Baseline vs. second time point: s=59, p=0.026; baseline vs. 6 months: s=75.5, p=0.005